15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 mice
- 17 Downloads
Treating MRL/1pr mice, which spontaneously develop systemic lupus erythematosus and rheumatoid arthritis, with 15-DOS resulted in a decrease in the amount of autoantibodies and inhibited proteinuria of the developing glomerulonephritis with an improved survival rate of these autoimmune mice. 15-DOS treatment also lowered the percentage of animals with swollen lymph nodes and inhibited the development of splenomegaly. In the established disease 15-DOS returned urine-protein values and renal function (serum urea and creatinine) to normal levels. Circulating rheumatoid factor and autoantibodies to double-stranded DNA were reduced and the increase in paw volume (signs of a polyarthritis) was inhibited.
KeywordsRheumatoid Arthritis Arthritis Urea Creatinine Renal Function
Unable to display preview. Download preview PDF.
- H. U. Schorlemmer, R. R. Barlett, R. Schleyerbach, G. Dickneite and F. R. Seiler,Immunosuppressive therapy of experimental autoimmune disease like rheumatoid arthritis and systemic lupus erythematosus by 15-Deoxyspergualin. Int. J. Immunotherapy5, 9–20 (1989).Google Scholar
- H. U. Schorlemmer, G. Dickneite, H. H. Sedlacek, and F. R. Seiler,Therapeutic treatment with 15-Deoxyspergualin (15-DOS) of acute and chronic relapsing experimental allergic encephalomyelitis (EAE), models for multiple sclerosis (MS). In:Recent Advances in Chemotherapy (Eds. E. Rubinstein and D. Adam) pp. 8611–8612, E. Lewin-Epstein Ltd. Offset Printers, Jerusalem, Israel (1989).Google Scholar
- E. D. Murphy and J. B. Roths,Autoimmunity and lymphoproliferation: induction by mutant gene 1pr and acceleration by a male-associated factor in strain BxSB mice. InGenetic control of autoimmune disease. (Eds. N. Rose, P. Bigazzi and N. Warner) Elsevier, North-Holland, New York, pp. 207–211 (1978).Google Scholar